KAKhalid Al-Hourani

Khalid Al-Hourani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Khalid Al-Hourani has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Boston All‐in‐One Medial Patellofemoral Complex Reconstruction: A Combined Medial Patellofemoral Ligament and Medial Quadriceps Tendon Femoral Ligament Dynamic Tensioning Technique Using Allograft

    by Khalid Al‐Hourani, Xinning Li

    Recent anatomical understanding of the medial restraints of the patella has evolved over the last decade with a current focus on the medial quadriceps tendon femoral ligament, a distinct anatomical structure to the medial patellofemoral ligament. These combine to form the medial patellofemoral complex. This technical note describes a technique to reconstruct the whole medial patellofemoral complex, replicating anatomical knowledge and allowing for dynamic graft tensioning using an allograft.

  • Open Access

    Primary anterior cruciate ligament reconstruction in female athlete-specific literature lacks standardization in outcome reporting

    by Brian Gibbs, Aikaterini Eleftheriadou, Jayson Saleet, Miho J. Tanaka, Xinning Li, Khalid Al-Hourani

    Aims: Female athletes sustain anterior cruciate ligament (ACL) ruptures at higher rates than male athletes. There is limited literature focusing on outcomes after ACL reconstruction (ACLR) in this population. The purpose of this study was to conduct a scoping review into female-specific literature for primary ACLR procedure, and to ascertain the variability in reporting outcomes in the literature. ‘Female’ was defined as sex assigned at birth for the purposes of this study. Methods: The systematic review was conducted according to PRISMA, and also used Arksey and O’Malley’s established five-stage process for scoping reviews to map the literature for primary ACLR in female-specific literature. After screening, data were extracted and mapped to provide a descriptive and thematic analysis. Results: A total of 1,172 studies were identified from the initial search with 16 studies eligible for final scoping review published from 2004 to 2024. Studies were identified from eight countries, with 9/16 (56.3%) from the USA. The mean age was 23.4 years (16 to 32). Key variables such as graft type (7/16, 43.8%) and graft diameter (2/16, 12.5%) were significantly under-reported. Of the functional outcomes, Tegner Activity Score was reported in seven studies (7/16, 43.8%), the International Knee Documentation Committee Score (IKDC) in six studies (6/16, 37.5%), and the Knee Injury and Osteoarthritis Outcome Score (KOOS) in six studies (6/16, 37.5%). Overall, 25 clinical outcomes were recorded spanning all studies including graft re-rupture (4/16, 25.0%), Lachman’s score (3/16, 18.8%), pivot shift (4/16, 25.0%), and return to sport (5/16, 31.3%). Conclusion: This review identified 16 studies which analyzed female-specific literature for primary ACLR over the last 20 years. There is a significant lack of studies in the literature reporting on female-specific outcomes, and in the eligible studies, there was a significant lack of standardization of variable and outcome reporting. Cite this article: Bone Jt Open 2026;7(5):692–703.


  • What’s New in Sports Medicine

    by Khalid Al-Hourani, Shehzaad Khan, Peter Boufadel, Tyler J. Uppstrom, Miho J. Tanaka, Robert L. Parisien, Richard Ma, Xinning Li

  • Open Access

    Medium-term functional outcomes comparing soft-tissue autografts with allografts in primary anterior cruciate ligament reconstruction

    by Saran Singh Gill, Aikaterini Eleftheriadou, Bhargava Ram Govardhana, Xinning Li, Shehzaad A. Khan, Fares S. Haddad, Khalid Al-Hourani

    Aims: Anterior cruciate ligament reconstruction (ACLR) is a widely performed procedure, yet the clinical and functional outcomes of soft-tissue autografts compared with allografts remain unclear. While previous studies have focused on surgical techniques and failure rates, few have systematically analyzed functional outcomes following ACLR. This study aimed to assess medium-term functional patient-reported outcome measures (PROMs) as the primary outcome and clinical outcomes as the secondary outcome following ACLR. Methods: A systematic review and meta-analysis followed PRISMA guidelines and was pre-registered on the Prospective Register of Systematic Reviews (PROSPERO). A comprehensive search of databases, including PubMed, Ovid MEDLINE, and Embase, was conducted up to June 2024. Eligible studies included skeletally mature patients undergoing primary ACLR, with reported clinical and functional outcomes at minimum 24 months. Data were analyzed using random-effects models to calculate standardized mean differences (SMDs) and odds ratios (ORs). Results: Of 5,292 studies screened, 12 were included, encompassing 1,038 patients. Of the functional scores, International Knee Documentation Committee (IKDC) outcomes (n = 930; SMD = 0.27; 95% CI 0.14 to 0.39; p < 0.001) and Tegner activity scores (n = 646; SMD = 0.18; 95% CI 0.03 to 0.34; p = 0.021) significantly favoured autografts, with Lysholm scores (n = 643; SMD = 0.14; 95% CI -0.02 to 0.29; p = 0.078) showing no significant differences between graft types. For clinical outcomes, Lachmann’s grades significantly favoured allografts (n = 346; SMD = -0.56; 95% CI -1.09 to -0.03; p = 0.037). Revision rates and graft re-tear rates did not differ significantly between graft types. Conclusion: The study found that autografts and allografts yield variable functional and clinical outcomes in ACLR at minimum 24-month follow-up, with autografts showing modest yet statistically significant advantage in IKDC and Tegner activity scores, but not in Lysholm functional score at and beyond 24 months. However, Lachmann’s scores suggested better stability with allografts. Cite this article: Bone Jt Open 2026;7(3):291–302.


  • Open Access

    Corrigendum

    by Khalid Al-Hourani, Saran Singh Gill, Bhargava Ram Govardhana, Eoghan Hurley, Shehzaad Khan, Alastair Davidson, Xinning Li, Iain R. Murray, Fares S. Haddad

  • Open Access

    Allografts in primary anterior cruciate ligament reconstruction

    by Khalid Al-Hourani, Saran Singh Gill, Bhargava Ram Govardhana, Eoghan Hurley, Shehzaad Khan, Alastair Davidson, Xinning Li, Iain R. Murray, Fares S. Haddad

    Aims: To conduct a scoping review into the use of allograft in primary anterior cruciate ligament (ACL) reconstruction, and to ascertain the variability in reporting outcomes in the literature.Methods: The study was conducted in line with the Preferred Reporting Items for Systematic reviews and Meta-Analayses (PRISMA), and also used Arksey and O’Malley’s established five-stage process for scoping reviews in order to map the literature for allograft use in primary ACL reconstruction. Following screening to identify eligible studies, data were extracted and mapped to provide a descriptive and thematic analysis.Results: A total of 421 studies were identified from the initial search, with 77 studies eligible for final scoping review published from January 1993 to December 2024. The majority of studies were published from the USA and China (56/77, 72.3%). Nine studies (9/77, 11.7%) were level1 evidence. Key variables such as graft diameter (27/77, 33.8%), graft processing (27/77, 35.1%), and cost of graft (3/77, 3.9%) were significantly under-reported. For clinical outcomes, the Lachman score (45/77, 57.1%), pivot shift grade (45/77, 58.4%), and graft re-rupture rate (42/77, 54.5%) were highest reported. For functional outcomes, two predominant scores were recorded, the International Knee Documentation Committee score (52/77, 67.5%) and the Tegner-Lysholm knee score (48/77, 62.3%). A total of 30 functional outcomes were recorded, spanning all studies.Conclusion: This scoping review identified 77 studies which analyzed allografts in primary ACL reconstruction. There is great variability in the reporting standards, with significant under-reporting of important variables. Further research is required to develop standardized reporting criteria in order to accurately reflect the outcomes of allografts in primary ACL reconstruction.Cite this article: Bone Jt Open 2025;6(8):933–943.


  • Allografts in soft-tissue knee surgery

    by Khalid Al-Hourani, Fares S. Haddad

    Allografts in soft-tissue knee surgery


  • What Is the Safe Window from Definitive Fixation to Flap Coverage in Type 3B Open Tibia Fractures? Supporting Plastics and Orthopaedics Alliance in Reducing Trauma Adverse Events (SPARTA)

    by Khalid Al-Hourani, Clary J. Foote, Andrew D. Duckworth, Tim O. White, Michael B. Kelly, Paul Tornetta, SPARTA Investigators

    Objectives: To delineate whether a “safe” window exists for timing from definitive fixation to definitive soft tissue coverage in the treatment of open tibial diaphyseal fractures requiring flap coverage. Design: International multicenter, retrospective comparative cohort study. Patients/Participants: Three hundred and seventy-three (n = 373) patients who sustained an open tibial shaft fracture requiring flap coverage. Methods: We evaluated the deep infection rates based on the timing between the definitive fixation and flap coverage. We determined several intervals of time from the day of definitive fixation (regardless of time from injury) and flap coverage. If performed on the same operative setting these were considered day 0. We evaluated coverage after 2 and 5 days from definitive fixation based on time versus infection rate curve inflection points. We adjusted for time to debridement and antibiotics within an hour. Main Outcome Measurement: Deep infection after definitive fixation and flap coverage. Results: The mean age of the cohort was 42.4 years (SD = 18.2) and 270 were male (72.4%). The deep infection rate after flap coverage was 20.6% (77/373). Definitive fixation to flap coverage time of up to 2 days was not associated with an increased risk of infection [relative risk (RR) = 1.12; 95% confidence interval, 0.92–1.37; P = 0.26]. There was an increased risk of deep infection for more than 2 days (RR = 1.59) and >5 days (RR = 1.64). Conclusion: This study observed a “safe” window of up to 2 days between definitive fixation and flap coverage in open tibial shaft fractures requiring coverage before a statistical increase in risk of deep infection rate occurred. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Osteoporosis: current screening methods, novel techniques, and preoperative assessment of bone mineral density

    by Khalid Al-Hourani, Shao-Ting Jerry Tsang, A. Hamish R. W. Simpson

    The British Editorial Society of Bone & Joint Surgery


  • Orthoplastic Reconstruction of Type IIIB Open Tibial Shaft Fractures Using Debrided, Devitalized Cortical Segments: Health-Related Quality-of-Life Outcomes

    by Khalid Al-Hourani, Oliver Pearce, Michael Stoddart, Andrew Riddick, Umraz Khan, Michael B. Kelly

    Objective: To determine health-related quality of life (HRQoL) in patients who sustained type IIIB open tibial diaphyseal (OTA/AO-42) fractures and underwent orthoplastic reconstruction using mechanically relevant devitalized bone (ORDB) versus those who did not require the use of devitalized bone as part of their orthoplastic reconstruction. Design: Consecutive cohort study. Patients/Participants: The study included 74 patients who sustained a type IIIB open tibial diaphyseal fracture requiring orthoplastic reconstruction over a 4-year period in a major trauma center. All patients underwent a two-stage orthoplastic reconstruction protocol, with the second stage consisting of definitive fixation and flap coverage (free fascial anterolateral thigh flap) in a single sitting. Patients were contacted at a minimum of 30 months to measure HRQoL. Intervention: Patients requiring ORDB versus those who did not require the use of devitalized bone as part of their orthoplastic reconstruction. Main Outcome Measurements: The primary outcome measure was HRQoL ascertained using Euro-Qol (EQ)-5D and Short-Form (SF)-36 scores. Results: Thirty (n = 30) patients underwent ORDB with the remaining 44 not requiring devitalized bone as part of their reconstruction. The median age was 46.5 years [interquartile range (IQR) 29.0], with a median follow-up of 3.8 years (IQR 1.5). The median cohort EQ-5D was 0.743 (IQR 0.222), ORDB 0.743 (IQR 0.195) versus non-ORDB 0.748 (IQR 0.285), P = 0.71. The median physical component SF-36 score was 80 (IQR 50), ORDB 80 (IQR 34.5) versus non-ORDB 77.5 (IQR 58.75), P = 0.72. The median mental component SF-36 score was 80 (IQR 28), ORDB 80 (IQR 21) versus non-ORDB 80 (IQR 36), P = 0.29. Conclusions: In patients who sustained a type IIIB open tibial shaft fracture and who underwent a 2-stage orthoplastic reconstruction, ORDB does not seem to be associated with inferior health-related quality of life based on EQ-5D or SF-36 scores. The results of this approach should be considered within the strict combined orthoplastic approach in the study unit. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.